Oral isotretinoin: Where now, where next?

Dermatology

Volumn 195, Issue 1, 1997, Pages 1-3

  Saurat, Jean Hilaire ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Acne; Isotretinoin; Retinoids

Indexed keywords

ANTIBIOTIC AGENT; AROTINOID; ETRETIN; ETRETINATE; ISOTRETINOIN; RETINOIC ACID;

ACNE; ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; HUMAN; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE; SEBACEOUS GLAND; SEBUM SECRETION; SKIN DISEASE; TERATOGENESIS;

ACNE VULGARIS; ADMINISTRATION, ORAL; HUMANS; ISOTRETINOIN; KERATOLYTIC AGENTS; SEBACEOUS GLANDS;

EID: 0030878470     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246011     Document Type: Article

References (19)

1. Peck GL. Olsen TG, Yoder FW. Strauss JS. Downing DT. Pandya M. Butkus D. Arnaud-Battandier J: Prolonged remissions of cystic and conglobata acne with I.Vcis-retinoic acid. N Engl J Med 1979;300:329-333.
2. Layton AM, Knaggs H, Taylor J. Cunliffe WJ: Isotretinoin for acne vulgaris-10 years later: A safe and successful treatment. Br J Dermatol 1993:129:292-296.
3. Farrell L. Strauss J. Stranieri A: The treatment of severe cystic acne with 13-cis-retinoic acid: Evaluation of sebum production and the clinical response in a multiple-dose trial. J Am Acad Dermatol 1980:3:602-611.
4. Doran T. Shapiro S: Retinoids effects on sebo-cyte proliferation; in Parckcr L (ed): Methods in Enzymology. San Diego. Academic Press. 1990, pp 334-338.
5. Shapiro SS. Bryce GF. Doran TL, McLane JA: Pharmacology and retinoids in models of photodamage and acne: in Livrea M. Vidali G (eds): Retinoids: From Basic Science to Clinical Applications. Basel. Birkhiiuser. 1994, pp 507-523.
6. Geiger JM. Hommel L. Harms M. Saurat J-H: Oral 13-cis retinoic acid superior to 9-cis retinoic acid in sebosuppression in human beings. J Am Acad Dermatol 1996;34:513-515.
7. Ott F. Bollag W. Geiger J-M: Oral 9-cis-ret-inoic acid versus 13-cis-rctinoic acid in acne therapy. Dermatology 1996:193:124-126.
8. Hommel L. Geiger J-M. Harms M. Saurat J-H: Sebum excretion rate in subjects treated with oral all-trans-rctinoic acid. Dermatology 1996; 193:127-130.
9. Stiittgen G. Braun-Falco O. Kligman AM. Grupper C: The therapeutic use of vitamin A acid. Acta Derm Vcncreol (Stockh) 1975:55 (Suppl) 741:17-185.
10. Harms M. Philippe I. Radeff B, Masouye I. Geiger J-M. Saurat J-H: Arotinoid Ro 13-6298 and etretin: Two new retinoids inferior to isotretinoin in sebum suppression and acne treatment. Acta Derm Venereol (Stockh) 1986; 66:149-154.
11. Saurat J-H, Merot Y. Borsky M. Abba Z. Hirschel-Scholz S: Arotinoid acid (Ro 13-7410): A pilot study in dermatology. Dermato-logica 1988:176:191-199.
12. Strauss JS, Davey WP, Denton SJ. Stranieri AM: Effect of an orally administered arotinoid. Ro 15-0778. on sebum production in man. Arch Dermatol Res 1988:280:152-154.
13. Sass JO. Masgrau E. Saurat J-H. Nau H: Metabolism of oral 9-cis retinoic acid in the human: Identification of 9-cis retinoyl b-glycuronide and 9-cis-oxo-retinoyl b-glycuronide as urine metabolites. Drug Mctab Dispos 1995:23: 887-891.
14. Adamson PC. Balis FM. Smith MA. Murphy RF, Godwin KA. Poplack DG: Dose-depen-dent pharmacokinetics of all-trans-retinoic-acid. J Natl Cancer Inst 1992:84:1332-1335.
15. Eckhoff C. Nau H: Vitamin A supplementation increases levels of retinoic acid compounds in human plasma: Possible implications for ter-atogenesis. Arch Toxicol 1990:64:502-503.
16. Nau H. Chahoud I. Dencker L. Lammer EJ. Scott WJ: Teratogenicity of vitamin A and retinoids: in Blomhoff R (ed): Vitamin A in Health and Disease. New York, Dekker. 1994. pp 615-664.
17. Lehucher-Ceyrac D. Weber-Buissct MJ: Isotretinoin and acne: A prospective analysis of 188 cases over 9 years. Dermatology 1993; 186:123-128.
18. Harms M. Duvanel T. Williamson C. Masouye I. Saurat J-H: Isotretinoin for acne: Should we consider the total cumulative dose?; in Marks R. Plewig G (eds): Acne and Related Disorders. London, Dunitz. 1989. pp 203-206.
19. Cunliffe WJ. van de Kerkhof PCM, Caputo R. Cavicehini S. Cooper A. Fyrand OL, Gollnick H, Layton AM. Leyden JJ. Mascaro J-M. Or-tonne J-P. Shalita A: Roaccutane treatment guidelines: Results of an international survey. Dermatology 1997;194:351-357.